Eli Lilly to invest $5B on Virginia plant amid Trump's pharma tariff threats

Core Viewpoint - Eli Lilly announced a $5 billion investment in a manufacturing facility in Virginia to expand domestic production capacity amid tariff threats [1][2] Group 1: Investment Details - The new facility will create 650 high-wage jobs and 1,800 construction jobs in Goochland County, Virginia [1] - This investment expands upon an earlier plan for a $2.1 billion facility that would have created 468 jobs [2] Group 2: Strategic Importance - Eli Lilly's CEO emphasized the commitment to U.S. innovation and manufacturing, aiming to strengthen the supply chain and support future medicines [3] - Virginia's Governor highlighted the significance of this investment for the local economy and the pharmaceutical supply chain [5] Group 3: Industry Context - The investment aligns with a broader trend of pharmaceutical companies increasing U.S. manufacturing amid potential tariffs on drug imports [6] - Earlier this year, Eli Lilly announced plans to invest at least $27 billion in four new U.S. manufacturing facilities to mitigate tariff risks [8]